JP Morgan upgraded Philips from Underweight to Neutral
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 12/17/2025 | Sector Perform | RBC Capital Mkts | |
| 2/25/2025 | Neutral → Outperform | Exane BNP Paribas | |
| 2/20/2025 | Neutral → Buy | UBS | |
| 10/29/2024 | Underperform → Hold | Jefferies | |
| 5/13/2024 | Mkt Perform → Outperform | Bernstein | |
| 5/7/2024 | Underperform → Neutral | Exane BNP Paribas | |
| 4/30/2024 | Sell → Neutral | UBS | |
| 4/30/2024 | Underweight → Neutral | JP Morgan |
RBC Capital Mkts initiated coverage of Philips with a rating of Sector Perform
Exane BNP Paribas upgraded Philips from Neutral to Outperform
July 8, 2026 Newest addition to the Philips ultrasound portfolio, Alturion recently received FDA 510(k) clearance and CE mark, expanding access to advanced imaging and workflow innovation across clinical settings Amsterdam, the Netherlands – Royal Philips (NYSE:PHG, AEX: PHIA)), a global leader in health technology, today announced the launch of the Alturion ultrasound system with AI-powered workflow built for high-volume settings. Available in the USA and Europe following FDA 510(k) clearance and CE mark certification, Alturion helps clinicians work more efficiently, deliver consistent results, and make confident clinical decisions. As healthcare providers manage growing demand and incre
Philips Sonicare Next-Generation DiamondClean 9900 Prestige lets users leave the guesswork behind, offering real-time guidance via light ring, on-device mouth map and smart pressure sensing to deliver 2000%1 more plaque removal and 1500%2 healthier gums vs manual brushing Royal Philips (NYSE:PHG, AEX: PHIA)), a global leader in oral healthcare, today announced its most advanced, intelligent electric toothbrush ever: the Philips Sonicare Next-Generation DiamondClean 9900 Prestige – a breakthrough in Sonicare's personalized oral care that empowers people to see how well they’re brushing in real-time. This press release features multimedia. View the full release here: https://www.businesswi
Long-term contract will unify monitoring technology, support data-driven care and enable scalable innovation across one of the largest, and growing public health systems in Texas Royal Philips, a global leader in health technology, and University Health in San Antonio today announced a strategic contract to modernize and standardize patient monitoring through Philips’ Enterprise Monitoring as a Service (EMaaS) model. The collaboration will transition University Health in San Antonio to a fully integrated Philips monitoring platform environment, supporting clinical workflows, alarm management initiatives and data-driven decision-making while creating a scalable foundation to support their
6-K - KONINKLIJKE PHILIPS NV (0000313216) (Filer)
SD - KONINKLIJKE PHILIPS NV (0000313216) (Filer)
6-K - KONINKLIJKE PHILIPS NV (0000313216) (Filer)
New findings show AI helping clinicians expand capacity, reduce burnout and deliver better care for more people amid rising demand, workforce shortages and increasing costs Royal Philips (NYSE:PHG, AEX: PHIA)), a global leader in health technology, today released its 2026 Future Health Index U.S. report, "AI in practice: Shaping the future of healthcare now," revealing how AI is delivering measurable benefits across healthcare systems under growing strain. The report shows AI increasingly embedded into clinical workflows, helping clinicians regain time, improve decision-making, expand patient capacity and reduce administrative burden. This press release features multimedia. View the full
June 2, 2026 Amsterdam, the Netherlands – Royal Philips (NYSE:PHG, AEX: PHIA)), today announced that the exchange ratio for the dividend for the year 2025 is 1 new common share for every 26.9341 existing common shares. This ratio was based on the volume-weighted average price of all traded common shares Koninklijke Philips N.V. at Euronext Amsterdam on May 27, 28 and 29, 2026, of EUR 22.8640 and was calculated in a manner that the gross dividend in shares will be approximately equal to EUR 0.85. As a result, Philips will issue a total number of 19,964,655 new common shares. Shareholders have been given the opportunity to make their choice between a dividend in shares or in cash. The aggreg
May 6, 2026Q1 2026 Group performance Comparable order intake growth 6% Group sales of EUR 3.9 billion, reflecting 4% increase in comparable salesIncome from operations increased to EUR 241 millionAdjusted EBITA margin increased 40 basis points to 9.0%Operating cash flow of EUR 188 million, with free cash flow of EUR 28 million2026 outlook reiterated Roy Jakobs, CEO of Royal Philips:"We delivered a good start to 2026, with strong order intake growth at 6%, comparable sales growth of 4% and margin expansion of 40 basis points, reflecting disciplined execution against our plan in an uncertain macro-environment. Sales grew across segments and was led by North America and Europe. We are moving
May 8, 2026 Amsterdam, the Netherlands – Royal Philips (NYSE:PHG, AEX: PHIA)), a global leader in health technology, today announced that its shareholders approved all proposals at the Annual General Meeting of Shareholders (AGM) 2026, including: Appointment of John DeFord (American, 1962) as new member of the Supervisory Board, with effect from May 8, 2026.Re-appointment of Paul Stoffels (Belgian, 1962), Herna Verhagen (Dutch, 1966) and Sanjay Poonen (American, 1969) as members of the Supervisory Board, with effect from May 8, 2026.Re-appointment of Roy Jakobs (Dutch/German, 1974) as President/CEO and Chairman and member of the Board of Management, with effect from May 8, 2026.Discharge o
March 23, 2026 John DeFord proposed as new member of the Supervisory Board.Paul Stoffels, Herna Verhagen and Sanjay Poonen proposed for re-appointment as members of the Supervisory Board.Marc Harrison will step down from Philips' Supervisory Board after his second term.Roy Jakobs proposed for re-appointment as President/CEO and Chairman and member of the Board of Management, as previously announced. Amsterdam, the Netherlands – Royal Philips (NYSE:PHG, AEX: PHIA)), a global leader in health technology, today announced a proposed Supervisory Board appointment and re-appointments, in addition to the previously announced proposal to re-appointment its President/CEO. The Supervisory Board wil
February 10, 2026 Amsterdam, the Netherlands – Royal Philips (NYSE:PHG, AEX: PHIA)), a global leader in health technology, today announced that Roy Jakobs is proposed to be re-appointed as its President/Chief Executive Officer and member of the Board of Management. The decision to propose the re-appointment of Roy Jakobs reflects the Supervisory Board's recognition of the progress made since 2022 and its confidence in his leadership as Philips enters the next phase of driving profitable growth. The proposal will be submitted for approval at the upcoming Annual General Meeting of Shareholders (AGM), to be held on May 8, 2026. "Roy Jakobs has demonstrated clear leadership, strong execution
SC 13D/A - KONINKLIJKE PHILIPS NV (0000313216) (Subject)
SC 13D/A - KONINKLIJKE PHILIPS NV (0000313216) (Subject)
SC 13D - KONINKLIJKE PHILIPS NV (0000313216) (Subject)